881673-33-2

Usage

Derivative of pyrrole

A modified version of the pyrrole molecule, which is a five-membered heterocyclic aromatic compound containing one nitrogen atom.

Contains a sulfonyl group

A functional group consisting of a sulfur atom double-bonded to two oxygen atoms (-SO2), which imparts specific chemical properties to the molecule.

Contains a phenyl group

A functional group consisting of a six-membered aromatic ring with five carbon atoms and one hydrogen atom (C6H5), which provides stability and versatility in chemical reactions.

Versatile reactivity

The compound can participate in various chemical reactions due to the presence of different functional groups, making it a valuable building block in organic synthesis.

Potential biological activities

The compound has been studied for its possible interactions with biological systems, which could lead to the development of new pharmaceuticals or other biologically active molecules.

Pharmaceutical intermediate

The compound may be used as a stepping stone in the synthesis of more complex molecules with potential pharmaceutical applications.

Building block for synthesis of biologically active molecules

The compound can serve as a starting point or key component in the creation of molecules with specific biological functions or therapeutic effects.

Need for further research

More studies are required to fully understand the properties, applications, and potential of 1H-Pyrrole-3-carboxaldehyde, 1-[(4-fluorophenyl)sulfonyl]-5-phenyl- in various fields, such as medicinal chemistry and organic synthesis.

Upstream product

• 114615-82-6 tetrapropylammonium perruthennate 
• 881673-32-1 {1-[(4-fluorophenyl)sulfonyl]-5-phenyl-1H-pyrrol-3-yl}methanol 

Relevant academic research and scientific papers

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

Proton pump inhibitors which have excellent proton pumping activity and which can be converted in vivo into proton pump inhibitors to exhibit antiulcer effect and so on, containing compounds represented by the general formula (I) or salts thereof or prodrugs of the same: (I) wherein X and Y are each independently a free valency or a spacer whose main chain has 1 to 20 carbon atoms; R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; R2, R3 and R4 are each independently hydrogen, an optionally substituted hydrocarbon group, optionally substituted thienyl, optionally substituted benzo[b]thienyl, optionally substituted furyl, optionally substituted pyridyl, optionally substituted pyrazolyl, optionally substituted pyrimidinyl, acyl, halogeno, cyano, or nitro; and R5 and R6 are each independently hydrogen or an optionally substituted hydrocarbon group.